↓ Skip to main content

Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000

Overview of attention for article published in European Journal of Clinical Pharmacology, November 2003
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
101 Mendeley
Title
Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000
Published in
European Journal of Clinical Pharmacology, November 2003
DOI 10.1007/s00228-003-0693-0
Pubmed ID
Authors

Andrew Boshier, Lynda V. Wilton, Saad A. W. Shakir

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 <1%
Spain 1 <1%
Canada 1 <1%
Unknown 98 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 13%
Student > Bachelor 12 12%
Student > Postgraduate 10 10%
Student > Master 10 10%
Researcher 9 9%
Other 24 24%
Unknown 23 23%
Readers by discipline Count As %
Medicine and Dentistry 31 31%
Psychology 8 8%
Agricultural and Biological Sciences 6 6%
Nursing and Health Professions 6 6%
Social Sciences 5 5%
Other 14 14%
Unknown 31 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 January 2022.
All research outputs
#7,713,391
of 25,371,288 outputs
Outputs from European Journal of Clinical Pharmacology
#853
of 2,744 outputs
Outputs of similar age
#19,975
of 59,886 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#2
of 10 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,744 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 59,886 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 8 of them.